AusVaxSafety commences routine monitoring of 2019 seasonal influenza vaccine in all ages

The AusVaxSafety active vaccine safety surveillance system monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues.

In 2018, 165,000 adults and children of all ages participated in surveillance and no safety signals were identified. Routine monitoring of the safety of the 2019 influenza vaccines in all ages commenced on 1 April 2019. Since then, more than 30,000 participants have provided feedback via SMS after their jab.

Vaccine safety results for the 2019 influenza vaccines will  be available on the AusVaxSafety website from Friday 12 April 2019 and updated weekly